| Followers | 38 |
| Posts | 4005 |
| Boards Moderated | 0 |
| Alias Born | 07/08/2002 |
Friday, September 17, 2021 12:13:03 PM
It is hard to identify the gist of the argument here.
"For the record, I’m confident the Brazil trials will NOT yield any approval. Every trial has failed thus far and they will not touch a company that the FDA put on alert and the SEC/DOJ is investigating. They’ll be bankrupt before then anyway. The last round of financing hasn’t been approved, there are not enough authorized shares to sell (MORE DILUTION) and the cash burn is too rapid."
But the gist is this: comments are solely based on speculation using phrases like "will NOT yield, they will not touch, they'll be bankrupt."
Everyone can have an opinion but the distance from the truth to speculation is typically a very long road.
That is why it is good to cite the truth because then, there is no WILL.
If in FACT, the above statements were TRUE, the summary "would" not have a "will" in it.
Try writing a sentence without "will," like this one: "I'm confident the Brazil trials will NOT yield any approval."
My turn: I am confident that the Brazil trials have begun. Upon conclusion, I look forward to their results.
"For the record, I’m confident the Brazil trials will NOT yield any approval. Every trial has failed thus far and they will not touch a company that the FDA put on alert and the SEC/DOJ is investigating. They’ll be bankrupt before then anyway. The last round of financing hasn’t been approved, there are not enough authorized shares to sell (MORE DILUTION) and the cash burn is too rapid."
But the gist is this: comments are solely based on speculation using phrases like "will NOT yield, they will not touch, they'll be bankrupt."
Everyone can have an opinion but the distance from the truth to speculation is typically a very long road.
That is why it is good to cite the truth because then, there is no WILL.
If in FACT, the above statements were TRUE, the summary "would" not have a "will" in it.
Try writing a sentence without "will," like this one: "I'm confident the Brazil trials will NOT yield any approval."
My turn: I am confident that the Brazil trials have begun. Upon conclusion, I look forward to their results.
Recent CYDY News
- Form 8-K - Current report • Edgar (US Regulatory) • 04/30/2026 08:32:50 PM
- CytoDyn Announces First Patient Dosed in Expanded Access Program for Leronlimab in Triple-Negative Breast Cancer • GlobeNewswire Inc. • 04/27/2026 12:30:00 PM
- CytoDyn to Host Investor Webcast • GlobeNewswire Inc. • 04/23/2026 12:30:00 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 04/22/2026 09:21:50 PM
- CytoDyn Presents New Leronlimab Data in Metastatic Colorectal Cancer at AACR Annual Meeting 2026 • GlobeNewswire Inc. • 04/22/2026 12:30:00 PM
- CytoDyn Completes Enrollment in Phase 2 Metastatic Colorectal Cancer Study • GlobeNewswire Inc. • 04/21/2026 08:10:00 PM
- CytoDyn Presents New Leronlimab Data in Metastatic Triple-Negative Breast Cancer at AACR Annual Meeting 2026 • GlobeNewswire Inc. • 04/20/2026 12:30:00 PM
- CytoDyn to Present at the AACR Annual Meeting 2026 • GlobeNewswire Inc. • 04/14/2026 12:30:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 04/08/2026 09:15:18 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 04/08/2026 12:30:28 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 03/25/2026 09:16:10 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:24:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:23:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:22:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:21:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:20:57 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:20:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/24/2026 09:15:24 PM
- CytoDyn Presents at AACR Special Conference in Cancer Research: Brain Cancer • GlobeNewswire Inc. • 03/24/2026 12:30:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 03/09/2026 09:15:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/05/2026 01:35:02 PM
- CytoDyn Closes $17.5 Million Financing to Fund Continued Development of Leronlimab • GlobeNewswire Inc. • 03/05/2026 01:30:00 PM
- CytoDyn Presents Novel CCR5 Inhibition Mechanisms and Long-Term Survival Signals for Leronlimab in Metastatic Breast Cancer at AACR Immuno-Oncology Conference • GlobeNewswire Inc. • 02/20/2026 01:30:00 PM
- CytoDyn Announces Funding and Initiation of Expanded Access Program for Patients with Triple-negative Breast Cancer • GlobeNewswire Inc. • 01/27/2026 01:30:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 01/09/2026 10:15:22 PM
